TRAF3-MYO16 Fusion FISH Probe
The TRAF3-MYO16 Fusion FISH Probe is used to confirm a fusion of the TRAF3 and MYO16 genes. The fusion of the TRAF3 and MYO16 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TRAF3-MYO16-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TRAF3-MYO16-20-AQAQ | 20 (40 μL) | 200 μL |
|
TRAF3 Gene Summary
The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from, members of the TNF receptor (TNFR) superfamily. This protein participates in the signal transduction of CD40, a TNFR family member important for the activation of the immune response. This protein is found to be a critical component of the lymphotoxin-beta receptor (LTbetaR) signaling complex, which induces NF-kappaB activation and cell death initiated by LTbeta ligation. Epstein-Barr virus encoded latent infection membrane protein-1 (LMP1) can interact with this and several other members of the TRAF family, which may be essential for the oncogenic effects of LMP1. Several alternatively spliced transcript variants encoding three distinct isoforms have been reported. [provided by RefSeq, Dec 2010]
Gene Name: TNF Receptor Associated Factor 3
Chromosome: CHR14: 103243815 -103377837
Locus: 14q32.32
MYO16 Gene Summary
This gene encodes an unconventional myosin protein. The encoded protein has been proposed to act as a serine/threonine phosphatase-1 targeting or regulatory subunit. Studies in a rat cell line suggest that this protein may regulate cell cycle progression. A variant within this gene may be associated with susceptibility to schizophrenia and elevated expression of this gene has been observed in the frontal cortex of human schizophrenia patients. [provided by RefSeq, Mar 2017]
Gene Name: Myosin XVI
Chromosome: CHR13: 109248499 -109860355
Locus: 13q33.3
Gene Diseases
The TRAF3 MYO16 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|